Brasil maior 2013
•
1 gefällt mir•2,212 views
Overview of the Greater Brazil Plan "Plano Brasil Maior" outlining a new industrial, technological, service and foreign trade policy for Brazil.
Empfohlen
Weitere ähnliche Inhalte
Was ist angesagt?
Ähnlich wie Brasil maior 2013
Ähnlich wie Brasil maior 2013 (20)
Kürzlich hochgeladen
Kürzlich hochgeladen (20)
Brasil maior 2013
- 2. Disclaimer This presentation was prepared in order to provide the general public a an updated overview on The Greater Brazil Plan (Plano Brasil Maior). The great majority of information contained in this presentation was originally published by the Brazilian Government and is of public domain. Therefore, the author of this work does not claim authorship and ownership of any information originally published elsewhere. The resources listed may direct the reader to local government agencies websites which content is communicated in Portuguese. The free translation content is made to the best of our knowledge. Therefore, Brazil Pharma News does not warrant the accuracy, reliability or timeliness of any information translated in the following slides. In addition, some items may not be fully translated into English, including graphs, photos or print screen documents. Brazil Pharma News does not endorse the use of any web translation tools; other translation services may be used to view our site. The information reported in this presentation does not necessarily reflect our official position on the subject, nor of any present or past associated employers of the author. Some web links may be time‐sensitive. These links may move or expire as the news changes throughout the time. Some sources may require registration or fee‐ based subscriptions. Any person or entities that rely on information obtained from the system does so at his or her own risk. The commercial use or unauthorized distribution of the contents in this presentation without prior consent is prohibited. If you have any suggestions or comments, please contact us by using the feedback form available at Contact Us. Brazil Pharma News
- 3. Federative Republic of Brazil • Population: 205 million people (July 2012 est.) • Total land are: 3,287,597 sq. mi. • GDP: US$ 2.324 trillion (2011) • GDP Growth: 2.7% (2011) • One major official language: Portuguese • Government: Presidential system, Constitutional republic, Federal republic • Population concentration in major urban areas: São Paulo, Rio de Janeiro, Belo Horizonte, Porto Alegre, Brasilia. • Urbanization: 40% metropolitan • Life expectancy at birth : 74.08 yrs (2011 est.) • Total health expenditures (2006): US$ 87.3 billion • Health expenditure as % GDP: 9 (2009) Sources: World Bank , World Fact Book: Central Intelligence Agency and IBGE (Brazilian Institute of Geography and Statistics)
- 4. Greater Brazil Plan “Innovate to compete. Compete to grow.” Source: Brasil Maior: Sectorial Strategic Agendas – April 2013
- 5. The Greater Brazil Plan “The Greater Brazil Plan is and industrial, technological and foreign trade policy from President Dilma Rousseff’s government (2011-Present). It arises in the context of the troubled world economy. In one side the developed countries plunged into unprecedented crisis since the Great Depression of 1929 which may lead the world into a systemic crisis. In the other side the economic strength of emerging countries, led by growth in China, has secured global growth and avoided the collapse. The challenge of the Greater Brazil Plan is therefore colossal: 1) sustain inclusive economic growth in an adverse economic environment, 2) step out of the international crisis in a better position, which would result in a structural change in the country's insertion in the world economy. Therefore, the Plan focuses on innovation and productive intensification of Brazilian industry, aiming sustained gains in labor productivity. Source: Brasil Maior: Sectorial Strategic Agendas – April 2013
- 6. “… The monetary stability, the return on investment and growth, the recovery in employment, real wage gains and the drastic reduction of poverty created favorable conditions for the country to make bolder steps in your journey toward a higher stage of development. The Plan will adopt important investment and exports exemption measures to start coping with the appreciation, advancement of credit and improvement of the regulatory framework for innovation, strengthening the defense and expansion of business tax incentives and facilitating financing for adding national value and competitiveness of supply chains. The country will mobilize its productive forces to innovate, compete and grow. The large and thriving market, the power of public procurement created by inclusive policies, the extensive energy resources to be explored, the young labor force and entrepreneurial creativity are institutional strengths, of natural and social resources to develop a formidable Greater Brazil.” The Greater Brazil Plan, cont’d Source: Brasil Maior: Sectorial Strategic Agendas – April 2013
- 7. The Greater Brazil Plan Executive Board MINISTRY OF INDUSTRY AND TRADE DEVELOPMENT. PRESIDENCY OF THE REPUBLIC CIVIL HOUSE. MINISTRY OF FINANCE. MINISTRY OF SCIENCE AND TECHNOLOGY. MINISTRY OF PLANNING, BUDGET AND MANAGEMENT. BRAZILIAN INDUSTRIAL DEVELOPMENT AGENCY. NATIONAL BANK FOR ECONOMIC AND SOCIAL DEVELOPMENT (BNDS). Financier of Studies and PROJECTS (FINEP). Source: Brasil Maior: Sectorial Strategic Agendas – April 2013
- 8. Council on Health Complex Competitiveness The Council on Health Complex Competitiveness is comprised of representatives in the following organizations: • Ministry of Health Secretary (MS). • Ministry of Development, Industry and Foreign Trade (MDIC). • Brazilian Agency for Industrial Development (ABDI). • Brazilian National Development Bank (BNDS). • Ministry of Science, Technology and Innovation (MCTI). • Ministry of Planning (MPOG). • Brazilian Association of Fine Chemical Industries, Biotechnology and its Specialties (ABIFINA). • Brazilian Association of Medical, Dental, Hospital and Laboratories Equipment Industries (ABIMO). • Brazilian Association of Pharmaceutical Chemistry and Pharmaceutical Supplies Industries (ABIQUIF). • Brazilian Association of Collective Health (ABRASCO). Source: Brasil Maior: Sectorial Strategic Agendas – April 2013
- 9. Council on Health Complex Competitiveness, cont’d • National Pharmaceutical Laboratories Association (ALANAC). • Association of Brazil’s Official Pharmaceutical Laboratories (ALFOB). • National Confederation of Industry (CNI). • National Municipal Health Council (CONASEMS). • National Health Departments Council (CONASS). • Brazil’s Central Workers Union (CUT). • FarmaBrazil Group (Grupo FARMABRASIL). • Federation of Industries of the State of São Paulo (FIESP). • São Paulo State Union’s Force (FORÇA SINDICAL). • Association of Pharmaceutical Research Industry (INTERFARMA). • New Trade Workers Union (NCST). • Brazilian Association of Generic Medicines Manufacturers (PROGENERICOS). • Institute for Research and Development of Drugs and Pharmaceutical Products(PROTEC / IPD-FARMA). • Society for the Advancement of Science (SBPC). • São Paulo state Pharmaceutical Industry Union (SINDUSFARMA). • General Workers Union (UGT). Source: Brasil Maior: Sectorial Strategic Agendas – April 2013
- 10. Focus and Priorities Focus Innovation and technological development Priorities To build and strengthen critical competencies in the national economy To enhance productivity and technology density within value chains To expand the domestic and external markets of Brazilian companies To ensure socially inclusive and environmentally sustainable growth Source: Plano Brasil Maior 2011/2014 (MDIC.gov.br)
- 13. Health Complex Agenda Goal: “Stimulate the production and reduce the country's dependence on equipment and materials for use in healthcare, pharmaceuticals (bioproducts and chemicals) and medicines (vaccines, blood products, etc.)” Source: Brasil Maior: Sectorial Strategic Agendas – April 2013
- 14. Health Complex Actions Expand partnerships for strategic health product development programs: mental health, STDs, AIDS, organ transplants, oncology, neglected diseases, vaccines. Deadline: 12/2014. Responsible: MS, SCTIE and DECIIS. Deploy SUS radiotherapy expansion plan. Deadline: 12/2014. Responsible: MS, SCTIE and DECIIS Set guidelines for offset practices – commercial, industrial and technology compensation within the health industrial complex. Deadline: 12/2014. Responsible: MS, SCTIE and DECIIS Support financially and technically the official laboratories inserted in the Health Industrial Complex Development Program (Procis). Deadline: 12/2014. Responsible: MS, SCTIE and DECIIS Promote the generation of innovations to renew the technology portfolio of large companies through small business startups. Deadline: 12/2014. Responsible: FINEP MS (MoH), SCITIE (Secretary of Science, Technology and Strategic Supplies , DECIIS (Dept of Industrial Complex and Health Innovation) Source: Brasil Maior: Sectorial Strategic Agendas – April 2013
- 15. Deploy training and professional qualification center in hospital medical equipment and pharmaceutical products. Deadline: 12/2014. Responsible: MS, SCTIE and DECIIS. Strengthen the Equivalence and Bioequivalence Network (Reqbio). Deadline: 12/2014. Responsible: MS, SCTIE and DECIIS Strengthen and expand the actions of qualification and certification of supplies used by the official laboratories. Deadline: 12/2014. Responsible: MS, SCTIE and DECISS. Encourage the offer of certified domestic products in health (national and international standards certifications Deadline: 12/2014. Responsible: FINEP. Improve the pharmaceutical products price control system Deadline: 12/2014. Responsible: CIMED. Health Complex Actions, cont’d Source: Brasil Maior: Sectorial Strategic Agendas – April 2013
- 16. Promote periodic updates on the NHS strategic products list. Deadline: 12/2014. Responsible: GECIS / MS. Systematically adjust the PIS / COFINS (taxes) to avoid incidence of higher rates for new products and active ingredients associations which are individually exempt Deadline: 12/2014. Responsible: MS and SCTIE. Adjust the tax burdens of domestic and imported health products for public procurement and social assistance entities. Deadline: 12/2014. Responsible: MS and SCTIE. Support the qualification of engineers, physicists, technicians in the areas of maintenance and development of hardware and software to work in radiotherapy and diagnostic radiology. Deadline: 12/2014. Responsible: MS, SCTIE and DECIIS. Deploy Supplier Qualification Program for the Medical Equipment and Supplies Industries, including specialized technical services for health. Deadline: 12/2014. Responsible: MS, SCTIE and DECIIS. Health Complex Actions, cont’d Source: Brasil Maior: Sectorial Strategic Agendas – April 2013
- 17. Consolidate and improve the health surveillance regulation, so as to enable research and production of the Industrial Health Complex. Deadline: 12/2014. Responsible: ANVISA. Expand funding for the development and production of biotech drugs. Deadline: 12/2014. Responsible: BNDES. Expand funding for the chain production of medical devices, hospital and dental equipment (EMHO). Deadline: 12/2014. Responsible: BNDES. Expand funding for the pharmaceutical supply chain. Deadline: 12/2014. Responsible: BNDES. Strengthen the integration of health care services to promote national production and innovation Deadline: 12/2014. Responsible: ANS. Health Complex Actions, cont’d Source: Brasil Maior: Sectorial Strategic Agendas – April 2013
- 18. Health Complex Agenda Goal: “Strengthen the research, development and innovation framework .” Source: Brasil Maior: Sectorial Strategic Agendas – April 2013
- 19. Train and strengthen research networks for the production of knowledge and scientific evidence in health (RNPC, REDEFAC, REBRATS, RNTC, RNPCC, RNPDN) Deadline: 12/2014. Responsible: MS, SCTIE and DECIT. Create and consolidate clinical pharmacology and cellular technology reference centers. Deadline: 12/2014. Responsible: MS, SCTIE, DECIT and FINEP). Qualify the process of ethical clinical research review and reduce time for analysis and approval of clinical research projects. Deadline: 12/2014. Responsible: MS, SCTIE and DECIT). Expand the use of instruments such as the "Science without Borders "to attract researchers with experience in preclinical research and clinical practice in the country. Deadline: 12/2014. Responsible: MS, SCTIE, DECIT, CNPq and Capes. Encourage preclinical trials projects and animal production bioteries. Deadline: 12/2014. Responsible: FINEP. Health Complex Actions Source: Brasil Maior: Sectorial Strategic Agendas – April 2013
- 20. Foster the development and application of new information and communication technologies in remote health care. Deadline: 12/2014. Responsible: FINEP. Create biotechnology institutes focusing on research, development and innovation Deadline: 12/2014. Responsible: MS, SCTIE, DECITe MDIC. Prioritize patent application analysis of NHS strategic pharmaceuticals and health products as decided by the Ministry of Health. Deadline: 12/2014. Responsible: INPI. Develop strategies for the medium and long-term adoption of new technologies for health products. Deadline: 12/2014. Responsible: MS, MCTI and MDIC. Health Complex Actions, cont’d Source: Brasil Maior: Sectorial Strategic Agendas – April 2013
- 21. Source: Retomada da Produção de Insulina MoH – April 2013 Ministry of Health Public Companies Great Brazil Plan: using the power of purchase Technology Centers Private Companies
- 26. Opportunities • A large and dynamic domestic market able to sustain growth even in the context of economic crisis in developed countries. • Favorable conditions in commodity markets that enable to sustain trade surplus. • Existence of a group of innovative companies capable of leading a manufacturing modernization process. • Accumulation of scientific competencies with potential to develop products and services with high technological content. • Abundance of natural resources, technological mastery, and entrepreneurial capacity in renewable energies and in the oil and gas chains. • Use of public procurement and large sporting events to leverage new businesses and technologies. Source: Plano Brasil Maior 2011/2014 (MDIC.gov.br)
- 27. Challenges • To strengthen the technological upgrading of the Brazilian manufacturing industry. • To deal with the effects of both the currency appreciation and the uncertainties of the international environment. • To face growing international competition in the domestic and international markets. • To accelerate investment in physical infrastructure. • To improve basic education and to promote professional qualification at technical and university levels, particularly in engineering‐related areas Source: Plano Brasil Maior 2011/2014 (MDIC.gov.br)
- 30. Contact Us Please check again in the future for more updates!